Clinical Scorecard: Assessing the Learning Curve for Robotic Pancreaticoduodenectomy Using CUSUM and Risk-Adjusted CUSUM in 120 Consecutive Cases
At a Glance
Category
Detail
Condition
Robotic pancreaticoduodenectomy (RPD) for benign or malignant periampullary diseases
Key Mechanisms
The study evaluates changes in operative performance and postoperative safety over case sequence using cumulative sum (CUSUM) and risk-adjusted CUSUM (RA-CUSUM) analyses.
Target Population
Consecutive patients undergoing RPD at a high-volume pancreatic surgery referral center; the supplied excerpt does not establish the study end date.
Care Setting
High-volume pancreatic surgery referral center with substantial expertise in open pancreatic surgery and a structured robotic program.
Key Highlights
The retrospective study used prospectively recorded institutional data from 120 consecutive RPD cases.
One surgeon performed all operations using a standardized, fully robotic Whipple procedure and intracorporeal Child’s reconstruction.
The primary endpoint was temporal change in postoperative safety assessed with RA-CUSUM.
The study also examined intraoperative performance and oncological adequacy during implementation of the robotic program.
Vascular resection was not an exclusion criterion; patients considered unsuitable for minimally invasive surgery were selected for open surgery.
Guideline-Based Recommendations
Diagnosis
The source describes a learning-curve study and does not provide diagnostic recommendations for periampullary disease.
Management
The study reports that RPD was preferred when technically feasible; open surgery was selected for anesthetic or technical contraindications to minimally invasive surgery.
The program used formal robotic training, dedicated observerships, and stepwise introduction of robotic pancreatic procedures.
Monitoring & Follow-up
The study assessed postoperative safety longitudinally using RA-CUSUM and evaluated operative performance using CUSUM.
Recorded outcomes included major morbidity, clinically relevant pancreatic fistula, delayed gastric emptying, post-pancreatectomy hemorrhage, reintervention, length of stay, and 30- and 90-day mortality.
Risks
The source states that pancreaticoduodenectomy is associated with considerable postoperative morbidity, including at high-volume centers.
Major morbidity was defined as a complication requiring intervention of Clavien–Dindo grade III or higher within 30 days.
Patient & Prescribing Data
Patients scheduled for RPD for benign or malignant periampullary disease; vascular resection did not exclude patients from the analysis.
All cases used a standardized fully robotic Whipple procedure with intracorporeal pancreaticojejunostomy, hepaticojejunostomy, and gastrojejunostomy. The source provides no medication or prescribing data.
Clinical Best Practices
The study reports a structured, stepwise pathway for establishing its robotic pancreatic surgery program, including formal training and dedicated observerships.
The source notes that operative efficiency and postoperative safety may follow different trajectories.
The study maintained consistent operative and reconstruction protocols during the learning-curve assessment.
The study used ISGPS criteria for clinically relevant pancreatic fistula, delayed gastric emptying, and post-pancreatectomy hemorrhage, and Royal College of Pathologists criteria for R1 resection.
by Giuseppe Quero, Matteo Aulicino, Lodovica Langellotti, Gloria Santoro, Giuseppe Massimiani, Flavia Taglioni, Giuseppe Daloiso, Roberta Menghi, Federica Marzi, Antonio Pio Tortorelli, Claudio Fiorillo, Claudia Ferrantone, Davide De Sio, Mario Lettieri, Rossella Sepe, Vincenzo Tondolo, Sergio Alfieri
